The advent of iPSCs has brought about a significant transformation in stem cell research,
opening up promising avenues for advancing cancer treatment. The formation of cancer is a …

Glioblastoma (GBM) is the most invasive and deadliest brain cancer in adults. Its inherent
heterogeneity has been designated as the main cause of treatment failure. Thus, a deeper …

Cancers contain a suite of genetically stable cells within an extracellular matrix, collectively
termed the tumor microenvironment (TME). The TME strongly influences disease outcome …

Glioblastoma is the most aggressive brain tumor with a median survival ranging from 6.2 to
16.7 months. The complex interactions between the tumor and the cells of tumor …

Simple Summary The current treatment options for medulloblastoma, the most common
malignant childhood brain cancer, are associated with many negative side effects and …

This review describes recent technological advances applied to glioblastoma (GBM), a brain
tumor with dismal prognosis. International consortial efforts suggest the presence of …

Gliomas constitute a diverse and complex array of tumors within the central nervous system
(CNS), characterized by a wide range of prognostic outcomes and responses to therapeutic …

Glioblastoma (GBM) is the most common malignancy of the central nervous system in adults.
GBM has high levels of therapy failure and its prognosis is usually dismal. The phenotypic …

Excessive deposition of extracellular matrix (ECM) is a hallmark of solid tumors; however, it
remains poorly understood which cellular and molecular components contribute to the …